Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.

Autor: Poursani EM; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Mercatelli D; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Raninga P; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Bell JL; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Saletta F; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Kohane FV; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Neumann DP; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Zheng Y; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Rouaen JRC; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Jue TR; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Michniewicz FT; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Schadel P; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Kasiou E; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Tsoli M; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Cirillo G; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy., Waters S; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Shai-Hee T; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Cazzoli R; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Brettle M; Katharina Gauss Light Microscopy Facility, University of New South Wales, Sydney, NSW, Australia., Slapetova I; Katharina Gauss Light Microscopy Facility, University of New South Wales, Sydney, NSW, Australia., Kasherman M; Katharina Gauss Light Microscopy Facility, University of New South Wales, Sydney, NSW, Australia., Whan R; Katharina Gauss Light Microscopy Facility, University of New South Wales, Sydney, NSW, Australia., Souza-Fonseca-Guimaraes F; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia., Vahdat L; Dartmouth Cancer Center, Lebanon, NH, USA., Ziegler D; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia., Lock JG; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Giorgi FM; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Khanna K; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Vittorio O; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia. ovittorio@ccia.org.au.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia. ovittorio@ccia.org.au.

Publikováno v: Cell & bioscience [Cell Biosci] 2023 Jul 21; Vol. 13 (1), pp. 132. Date of Electronic Publication: 2023 Jul 21.

Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models.

Autor: Wang NF; School of Medical Sciences UNSW Sydney Sydney NSW Australia.; Prince of Wales Clinical School UNSW Sydney Sydney NSW Australia., Jue TR; Prince of Wales Clinical School UNSW Sydney Sydney NSW Australia., Holst J; School of Medical Sciences UNSW Sydney Sydney NSW Australia.; Prince of Wales Clinical School UNSW Sydney Sydney NSW Australia., Gunter JH; Australian Prostate Cancer Research Centre-Queensland, Centre for Genomic and Personalised Health, School of Biomedical Sciences, Faculty of Health, Translational Research Institute Queensland University of Technology (QUT) Brisbane QLD Australia.

Publikováno v: BJUI compass [BJUI Compass] 2022 Sep 30; Vol. 4 (1), pp. 44-58. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2023).

Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.

Autor: Khanna A; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia. jpimanda@unsw.edu.au a.khanna@unsw.edu.au.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Thoms JAI; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; School of Medical Sciences, University of New South Wales Sydney, New South Wales, Australia., Stringer BW; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Chung SA; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Ensbey KS; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Jue TR; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Jahan Z; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Subramanian S; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Anande G; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Shen H; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, Westmead, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia., Unnikrishnan A; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., McDonald KL; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia., Day BW; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pimanda JE; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia. jpimanda@unsw.edu.au a.khanna@unsw.edu.au.; Prince of Wales Clinical School, University of New South Wales Sydney, New South Wales, Australia.; School of Medical Sciences, University of New South Wales Sydney, New South Wales, Australia.; Department of Haematology, Prince of Wales Hospital, Randwick, New South Wales, Australia.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2020 May; Vol. 18 (5), pp. 709-722. Date of Electronic Publication: 2020 Feb 20.

The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.

Autor: Lu VM; Cure Brain Cancer Neuro-oncology Laboratory, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. Electronic address: victor.lu@student.unsw.edu.au., Jue TR; Cure Brain Cancer Neuro-oncology Laboratory, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia., McDonald KL; Cure Brain Cancer Neuro-oncology Laboratory, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia., Rovin RA; Aurora Neuroscience Innovation Institute, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, USA.

Publikováno v: World neurosurgery [World Neurosurg] 2018 Jul; Vol. 115, pp. 453-459.e3. Date of Electronic Publication: 2018 Apr 11.

Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.

Autor: Lu VM; Cure Brain Cancer Foundation Biomarkers and Translational Research Group, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia. Electronic address: victor.lu@student.unsw.edu.au., Jue TR; Cure Brain Cancer Foundation Biomarkers and Translational Research Group, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia., Phan K; NeuroSpine Surgery Research Group (NSURG), Prince of Wales Private Hospital, Randwick, Sydney, Australia., McDonald KL; Cure Brain Cancer Foundation Biomarkers and Translational Research Group, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.

Publikováno v: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2018 Jan; Vol. 164, pp. 75-80. Date of Electronic Publication: 2017 Dec 01.